secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2025-03-31T23:59:59+00:00
Accession:  0001641172-25-001751
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences closes $1.1M registered direct offering and private placement of warrants
--------------------------------------------------------------------------------

- Gross proceeds of approximately $1.1M from sale of 315,188 shares (or equivalents) at $3.49/share.
- Concurrent private placement: Series A-5 warrants (18-month term) and Series A-6 warrants (5-year term), each exercisable at $3.24/share.
- Net proceeds of ~$0.9M to fund TAAP and MPAR program development and working capital.
- H.C. Wainwright acted as exclusive placement agent; placement agent warrants for 22,063 shares at $4.3625/share.
- 30-day lock-up on further equity issuance and insider sales; beneficial ownership limitation of 4.99% (or 9.99%) on warrant exercise.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000164117225001751/0001641172-25-001751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000164117225001751/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-001751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer